These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1136 related articles for article (PubMed ID: 32673060)
21. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502 [TBL] [Abstract][Full Text] [Related]
22. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial. Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502 [TBL] [Abstract][Full Text] [Related]
23. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU. Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V; Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163 [TBL] [Abstract][Full Text] [Related]
24. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Lother SA; Abassi M; Agostinis A; Bangdiwala AS; Cheng MP; Drobot G; Engen N; Hullsiek KH; Kelly LE; Lee TC; Lofgren SM; MacKenzie LJ; Marten N; McDonald EG; Okafor EC; Pastick KA; Pullen MF; Rajasingham R; Schwartz I; Skipper CP; Turgeon AF; Zarychanski R; Boulware DR Can J Anaesth; 2020 Sep; 67(9):1201-1211. PubMed ID: 32383125 [TBL] [Abstract][Full Text] [Related]
25. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611 [TBL] [Abstract][Full Text] [Related]
27. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19. Casey JD; Johnson NJ; Semler MW; Collins SP; Aggarwal NR; Brower RG; Chang SY; Eppensteiner J; Filbin M; Gibbs KW; Ginde AA; Gong MN; Harrell F; Hayden DL; Hough CL; Khan A; Leither LM; Moss M; Oldmixon CF; Park PK; Reineck LA; Ringwood NJ; Robinson BRH; Schoenfeld DA; Shapiro NI; Steingrub JS; Torr DK; Weissman A; Lindsell CJ; Rice TW; Thompson BT; Brown SM; Self WH Ann Am Thorac Soc; 2020 Sep; 17(9):1144-1153. PubMed ID: 32492354 [TBL] [Abstract][Full Text] [Related]
28. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). Mercuro NJ; Yen CF; Shim DJ; Maher TR; McCoy CM; Zimetbaum PJ; Gold HS JAMA Cardiol; 2020 Sep; 5(9):1036-1041. PubMed ID: 32936252 [TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial. Tirupakuzhi Vijayaraghavan BK; Jha V; Rajbhandari D; Myatra SN; John O; Ghosh A; Bassi A; Arfin S; Kunigari M; Joshi R; Donaldson L; Hammond N; Venkatesh B; Trials; 2020 Aug; 21(1):754. PubMed ID: 32867852 [TBL] [Abstract][Full Text] [Related]
30. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada. Wright JK; Tan DHS; Walmsley SL; Hulme J; O'Connor E; Snider C; Cheng I; Chan AK; Borgundvaag B; McLeod S; Gollob MH; Clarke RJ; Dresser L; Haji F; Mazzulli T; Mubareka S; Jüni P; Lee D; Tomlinson G; Kain KC; Landes M Trials; 2020 Jul; 21(1):647. PubMed ID: 32665039 [TBL] [Abstract][Full Text] [Related]
31. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial. Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613 [TBL] [Abstract][Full Text] [Related]
32. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review. Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM Ann Intern Med; 2020 Aug; 173(4):287-296. PubMed ID: 32459529 [TBL] [Abstract][Full Text] [Related]
33. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743 [TBL] [Abstract][Full Text] [Related]
34. Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. Calderón JM; Zerón HM; Padmanabhan S Trials; 2020 Jun; 21(1):504. PubMed ID: 32513231 [TBL] [Abstract][Full Text] [Related]
35. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. Cavalcanti AB; Zampieri FG; Rosa RG; Azevedo LCP; Veiga VC; Avezum A; Damiani LP; Marcadenti A; Kawano-Dourado L; Lisboa T; Junqueira DLM; de Barros E Silva PGM; Tramujas L; Abreu-Silva EO; Laranjeira LN; Soares AT; Echenique LS; Pereira AJ; Freitas FGR; Gebara OCE; Dantas VCS; Furtado RHM; Milan EP; Golin NA; Cardoso FF; Maia IS; Hoffmann Filho CR; Kormann APM; Amazonas RB; Bocchi de Oliveira MF; Serpa-Neto A; Falavigna M; Lopes RD; Machado FR; Berwanger O; N Engl J Med; 2020 Nov; 383(21):2041-2052. PubMed ID: 32706953 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C Trials; 2020 May; 21(1):422. PubMed ID: 32448345 [TBL] [Abstract][Full Text] [Related]
37. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center. Lubetzky M; Aull MJ; Craig-Schapiro R; Lee JR; Marku-Podvorica J; Salinas T; Gingras L; Lee JB; Sultan S; Kodiyanplakkal RP; Hartono C; Saal S; Muthukumar T; Kapur S; Suthanthiran M; Dadhania DM Nephrol Dial Transplant; 2020 Jul; 35(7):1250-1261. PubMed ID: 32678882 [TBL] [Abstract][Full Text] [Related]
39. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study. Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873 [TBL] [Abstract][Full Text] [Related]
40. Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Hanna CR; Blyth KG; Burley G; Carmichael S; Evans C; Hinsley S; Khadra I; Khoo S; Lewsley LA; Jones RR; Sharma R; Taladriz-Sender A; Thomson EC; Scott JT Trials; 2020 Nov; 21(1):935. PubMed ID: 33213530 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]